Eko Health Raises $41 Million to Scale AI-Driven Heart & Lung Disease Detection
- 6.5.2024
On June 5, 2024, Eko Health, a pioneer in applying artificial intelligence for early detection of heart and lung diseases, announced it has raised $41 million in Series D financing. With by ARTIS Ventures, Highland Capital Partners, NTTVC and Questa Capital, the funding round will be used to expand US and global access to the company’s early disease detection platform.
The WilmerHale team advising Eko Health consisted of Joe Wyatt, Shafi Armatis and Sharon Baek.
